HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Phase II study of high dose ifosfamide plus mesna in inoperable non small cell lung carcinoma.

AuthorsZ Pastran, T le Chevalier, P Baldeyrou, M Spielmann, R Arriagada, J P Droz, J Rouesse
JournalEuropean journal of cancer & clinical oncology (Eur J Cancer Clin Oncol) Vol. 24 Issue 6 Pg. 1073-4 (Jun 1988) ISSN: 0277-5379 [Print] England
PMID2842161 (Publication Type: Journal Article)
Chemical References
  • Mesna
  • Ifosfamide
Topics
  • Adult
  • Aged
  • Antineoplastic Combined Chemotherapy Protocols (therapeutic use)
  • Carcinoma, Non-Small-Cell Lung (drug therapy)
  • Drug Evaluation
  • Female
  • Humans
  • Ifosfamide (administration & dosage)
  • Lung Neoplasms (drug therapy)
  • Male
  • Mesna (therapeutic use)
  • Middle Aged

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: